CD4 and myeloid sarcoma: However, the intracerebral anti-JC virus CD4+ T cell response contributes substantially to JCV control because efficient clearance of JC virus from the CNS after immune reconstitution by wash-out of natalizumab in MS patients with PML is associated with the re-occurrence of Th1 cells in the CNS [53].